Clinical Trials Browser

Phase 1 × Breast Neoplasms × balixafortide × Clear all

NCT01837095 2018-09-14

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms